The anti‐PD‐L1‐DOX‐R848‐MIP‐3α/TKNP provided better tumor specificity due to the construction of tumor (PD‐L1) and tumor‐microenvironment (ROS)‐responsive nanosystem. Here, CCL20 is linked to neoplasm.